[1]
T. Jomidava, “Does optimized adherence support improve treatment outcomes in RR / MDR-TB patients on 18-20 months regimen in Tbilisi, Georgia?”, J Infect Dev Ctries, vol. 15, no. 09.1, p. 34S-42S, Sep. 2021.